Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-05-12

AUTHORS

Joachim Schessl, Birgit Luther, Janbernd Kirschner, Gottfried Mauff, Rudolf Korinthenberg

ABSTRACT

IntroductionWe performed a prospective, multicentre study in children with Guillain-Barré syndrome (GBS), diagnosed according to international criteria, to investigate the frequency and aetiology of antecedent diseases. All infections and vaccinations occurring within a 6-week period prior to the onset of GBS were documented.Materials and methodsStool cultures, standardised serological investigations and PCR analyses for 24 different infective agents were performed. Serological findings were regarded as significant if specific immunoglobulin (Ig)M or IgA antibodies were detected, if the IgM enzyme immunoassay or immunfluorescence assay findings were confirmed by immunoblot, if complement fixation test titres rose fourfold or if geometric titres were more than threefold higher than in uninfected control persons. Ninety-five children with GBS were included in the study over a 40-month period. Preceding events were reported in 82%.ResultsMicrobiological studies carried out on 84 patients resulted in a probable diagnosis in 46 (55%). Coxsackieviruses (15%), Chlamydia pneumoniae (8%), cytomegalovirus (7%) and Mycoplasma pneumoniae (7%) were the most frequently involved agents. Serological evidence of a Campylobacter jejuni infection was found in six patients (7%). Eight children had been vaccinated during the 6 weeks preceding the onset of GBS; in six of these children concomitant infectious diseases were reported, and in one child the time between vaccination and GBS was extremely short.ConclusionWe conclude that, in contrast to adults, Campylobacter spp. does not seem to play a major role in childhood GBS in German-speaking countries. The aetiology of antecedent diseases is distributed over a wide spectrum of paediatric infectious diseases. Most of the children who had been vaccinated showed concomitant infectious diseases, thus obscuring the causative role for GBS. More... »

PAGES

605

References to SciGraph publications

  • 1990. Guillain-Barré Syndrome in NONE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00431-006-0140-1

    DOI

    http://dx.doi.org/10.1007/s00431-006-0140-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1017397789

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/16691408


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Bacterial", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antibodies, Viral", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Austria", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bacterial Vaccines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child, Preschool", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Virus Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Viruses", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fluorescent Antibody Technique", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Germany", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gram-Negative Bacteria", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gram-Negative Bacterial Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Guillain-Barre Syndrome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoenzyme Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin A", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin G", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunoglobulin M", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA Virus Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA Viruses", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Serologic Tests", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sweden", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vaccination", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Viral Vaccines", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7708.8", 
              "name": [
                "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schessl", 
            "givenName": "Joachim", 
            "id": "sg:person.01044643445.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044643445.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Microbiology and Hygiene, Institute of Hygiene and Environment, Hamburg, Germany", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Department of Clinical Microbiology and Hygiene, Institute of Hygiene and Environment, Hamburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Luther", 
            "givenName": "Birgit", 
            "id": "sg:person.01126132362.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126132362.31"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7708.8", 
              "name": [
                "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kirschner", 
            "givenName": "Janbernd", 
            "id": "sg:person.0717435623.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717435623.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory Dr. Kramer and Colleagues, Geesthacht, Germany", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Laboratory Dr. Kramer and Colleagues, Geesthacht, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mauff", 
            "givenName": "Gottfried", 
            "id": "sg:person.0646625744.89", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646625744.89"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.7708.8", 
              "name": [
                "Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Korinthenberg", 
            "givenName": "Rudolf", 
            "id": "sg:person.0704771463.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704771463.02"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-1-4471-3175-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033981631", 
              "https://doi.org/10.1007/978-1-4471-3175-5"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2006-05-12", 
        "datePublishedReg": "2006-05-12", 
        "description": "IntroductionWe performed a prospective, multicentre study in children with Guillain-Barr\u00e9 syndrome (GBS), diagnosed according to international criteria, to investigate the frequency and aetiology of antecedent diseases. All infections and vaccinations occurring within a 6-week period prior to the onset of GBS were documented.Materials and methodsStool cultures, standardised serological investigations and PCR analyses for 24 different infective agents were performed. Serological findings were regarded as significant if specific immunoglobulin (Ig)M or IgA antibodies were detected, if the IgM enzyme immunoassay or immunfluorescence assay findings were confirmed by immunoblot, if complement fixation test titres rose fourfold or if geometric titres were more than threefold higher than in uninfected control persons. Ninety-five children with GBS were included in the study over a 40-month period. Preceding events were reported in 82%.ResultsMicrobiological studies carried out on 84 patients resulted in a probable diagnosis in 46 (55%). Coxsackieviruses (15%), Chlamydia pneumoniae (8%), cytomegalovirus (7%) and Mycoplasma pneumoniae (7%) were the most frequently involved agents. Serological evidence of a Campylobacter jejuni infection was found in six patients (7%). Eight children had been vaccinated during the 6\u00a0weeks preceding the onset of GBS; in six of these children concomitant infectious diseases were reported, and in one child the time between vaccination and GBS was extremely short.ConclusionWe conclude that, in contrast to adults, Campylobacter spp. does not seem to play a major role in childhood GBS in German-speaking countries. The aetiology of antecedent diseases is distributed over a wide spectrum of paediatric infectious diseases. Most of the children who had been vaccinated showed concomitant infectious diseases, thus obscuring the causative role for GBS.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00431-006-0140-1", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1017354", 
            "issn": [
              "0340-6199", 
              "1432-1076"
            ], 
            "name": "European Journal of Pediatrics", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "165"
          }
        ], 
        "keywords": [
          "Guillain-Barr\u00e9 syndrome", 
          "onset of GBS", 
          "childhood Guillain-Barr\u00e9 syndrome", 
          "antecedent disease", 
          "infectious diseases", 
          "different infective agents", 
          "concomitant infectious disease", 
          "pediatric infectious diseases", 
          "IgM enzyme immunoassay", 
          "Campylobacter jejuni infection", 
          "complement fixation test titres", 
          "IgA antibodies", 
          "multicentre study", 
          "prospective study", 
          "serological findings", 
          "Chlamydia pneumoniae", 
          "serological evidence", 
          "jejuni infection", 
          "control persons", 
          "probable diagnosis", 
          "specific immunoglobulins", 
          "serological investigations", 
          "causative role", 
          "infective agents", 
          "enzyme immunoassay", 
          "Mycoplasma pneumoniae", 
          "vaccination", 
          "disease", 
          "international criteria", 
          "infection", 
          "patients", 
          "children", 
          "Campylobacter spp", 
          "syndrome", 
          "etiology", 
          "titres", 
          "pneumoniae", 
          "PCR analysis", 
          "onset", 
          "wide spectrum", 
          "major role", 
          "IntroductionWe", 
          "cytomegalovirus", 
          "agents", 
          "findings", 
          "study", 
          "immunoglobulin", 
          "diagnosis", 
          "weeks", 
          "antibodies", 
          "immunfluorescence", 
          "coxsackievirus", 
          "adults", 
          "period", 
          "immunoblot", 
          "immunoassay", 
          "ConclusionWe", 
          "role", 
          "persons", 
          "evidence", 
          "criteria", 
          "contrast", 
          "events", 
          "culture", 
          "spp", 
          "frequency", 
          "time", 
          "countries", 
          "investigation", 
          "analysis", 
          "materials", 
          "German", 
          "spectra"
        ], 
        "name": "Infections and vaccinations preceding childhood Guillain-Barr\u00e9 syndrome: a prospective study", 
        "pagination": "605", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1017397789"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00431-006-0140-1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "16691408"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00431-006-0140-1", 
          "https://app.dimensions.ai/details/publication/pub.1017397789"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-10T09:54", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_416.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00431-006-0140-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00431-006-0140-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00431-006-0140-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00431-006-0140-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00431-006-0140-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    288 TRIPLES      22 PREDICATES      129 URIs      120 LITERALS      36 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00431-006-0140-1 schema:about N088aebd50ba8479bb4dabb873da3e1e5
    2 N0f9a56ffcc1f4024b927bc3969e7ac03
    3 N10d8312519f445538cb1049b2b333dc5
    4 N17c01db3b1664369bb5d4b8ce0c1d326
    5 N1b009886208f4b13828505c0ec632dcc
    6 N34e40dc06f6947a595c4a0d781a9ed14
    7 N3554944d37ae4ba18a5c3311f83a5ba3
    8 N3f923e40e73e46089d0498bfe489bd3c
    9 N40b42c373f5c413bbbf117dfad861ef6
    10 N4520acea0e564b0fac12363d516b4103
    11 N48c6f598d30147819ef4767133742ad2
    12 N56f97bd5e0e14638a50c3ef44297eab7
    13 N6540303ae38c491997e97572f6c85c6b
    14 N6c56fb43f1154a6492d868149f783ec2
    15 N9080fbf7fca24ece9e1e2bc81b0639cb
    16 N917c878e73134dfcabef5d0088168cb4
    17 N9314dc5bc2614f5aa44097a404fcd7de
    18 N9a1caa90fc984db28dce68687c9ba18b
    19 N9c746249d3a74a57a3924d0f8c20abef
    20 N9cd47f74b7044f83a8453a247fe91300
    21 Nb503077d02e744b4bfece40c10bf22f8
    22 Nb5c45a001f004bfaa75377a61be568e6
    23 Nbe9422873c3445d09008ea2597db303c
    24 Nc6037757ade74ceb903bb4e0417e741e
    25 Nc7fa35b995594ba8957a851e8f8f260a
    26 Ncee9c762fc9349ddb76bdfdfa7c1c34d
    27 Nd57ec34405c34dc6ab5c1b671203b906
    28 Nd981269156154b7ba1b612e53c783cc6
    29 Necd7667c0c9647e58ba9c3c6e45b3367
    30 anzsrc-for:11
    31 anzsrc-for:1103
    32 schema:author N816702b4c27c472cb62c9e6ec64f9b6c
    33 schema:citation sg:pub.10.1007/978-1-4471-3175-5
    34 schema:datePublished 2006-05-12
    35 schema:datePublishedReg 2006-05-12
    36 schema:description IntroductionWe performed a prospective, multicentre study in children with Guillain-Barré syndrome (GBS), diagnosed according to international criteria, to investigate the frequency and aetiology of antecedent diseases. All infections and vaccinations occurring within a 6-week period prior to the onset of GBS were documented.Materials and methodsStool cultures, standardised serological investigations and PCR analyses for 24 different infective agents were performed. Serological findings were regarded as significant if specific immunoglobulin (Ig)M or IgA antibodies were detected, if the IgM enzyme immunoassay or immunfluorescence assay findings were confirmed by immunoblot, if complement fixation test titres rose fourfold or if geometric titres were more than threefold higher than in uninfected control persons. Ninety-five children with GBS were included in the study over a 40-month period. Preceding events were reported in 82%.ResultsMicrobiological studies carried out on 84 patients resulted in a probable diagnosis in 46 (55%). Coxsackieviruses (15%), Chlamydia pneumoniae (8%), cytomegalovirus (7%) and Mycoplasma pneumoniae (7%) were the most frequently involved agents. Serological evidence of a Campylobacter jejuni infection was found in six patients (7%). Eight children had been vaccinated during the 6 weeks preceding the onset of GBS; in six of these children concomitant infectious diseases were reported, and in one child the time between vaccination and GBS was extremely short.ConclusionWe conclude that, in contrast to adults, Campylobacter spp. does not seem to play a major role in childhood GBS in German-speaking countries. The aetiology of antecedent diseases is distributed over a wide spectrum of paediatric infectious diseases. Most of the children who had been vaccinated showed concomitant infectious diseases, thus obscuring the causative role for GBS.
    37 schema:genre article
    38 schema:inLanguage en
    39 schema:isAccessibleForFree false
    40 schema:isPartOf N14717a2dbdec4e7f9899a45a3df385b8
    41 N23a7f9daaaf6484f80dc816eacb1e532
    42 sg:journal.1017354
    43 schema:keywords Campylobacter jejuni infection
    44 Campylobacter spp
    45 Chlamydia pneumoniae
    46 ConclusionWe
    47 German
    48 Guillain-Barré syndrome
    49 IgA antibodies
    50 IgM enzyme immunoassay
    51 IntroductionWe
    52 Mycoplasma pneumoniae
    53 PCR analysis
    54 adults
    55 agents
    56 analysis
    57 antecedent disease
    58 antibodies
    59 causative role
    60 childhood Guillain-Barré syndrome
    61 children
    62 complement fixation test titres
    63 concomitant infectious disease
    64 contrast
    65 control persons
    66 countries
    67 coxsackievirus
    68 criteria
    69 culture
    70 cytomegalovirus
    71 diagnosis
    72 different infective agents
    73 disease
    74 enzyme immunoassay
    75 etiology
    76 events
    77 evidence
    78 findings
    79 frequency
    80 immunfluorescence
    81 immunoassay
    82 immunoblot
    83 immunoglobulin
    84 infection
    85 infectious diseases
    86 infective agents
    87 international criteria
    88 investigation
    89 jejuni infection
    90 major role
    91 materials
    92 multicentre study
    93 onset
    94 onset of GBS
    95 patients
    96 pediatric infectious diseases
    97 period
    98 persons
    99 pneumoniae
    100 probable diagnosis
    101 prospective study
    102 role
    103 serological evidence
    104 serological findings
    105 serological investigations
    106 specific immunoglobulins
    107 spectra
    108 spp
    109 study
    110 syndrome
    111 time
    112 titres
    113 vaccination
    114 weeks
    115 wide spectrum
    116 schema:name Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study
    117 schema:pagination 605
    118 schema:productId N91bddd1b5e374850bef2bdd8a43dd24a
    119 Nc6add0aecfff48fc8ecb9aa578c6a670
    120 Nda2dbe47d3374125afc7fcb09a9eb0da
    121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017397789
    122 https://doi.org/10.1007/s00431-006-0140-1
    123 schema:sdDatePublished 2022-05-10T09:54
    124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    125 schema:sdPublisher N7ffb69a5df38413b97c9a1273dfd626a
    126 schema:url https://doi.org/10.1007/s00431-006-0140-1
    127 sgo:license sg:explorer/license/
    128 sgo:sdDataset articles
    129 rdf:type schema:ScholarlyArticle
    130 N088aebd50ba8479bb4dabb873da3e1e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name RNA Viruses
    132 rdf:type schema:DefinedTerm
    133 N0ab1304648804cf7bf6aeafcb04d4b84 rdf:first sg:person.01126132362.31
    134 rdf:rest N1c699812ed054f6f8dce8cbf464beda9
    135 N0f9a56ffcc1f4024b927bc3969e7ac03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Infant
    137 rdf:type schema:DefinedTerm
    138 N10d8312519f445538cb1049b2b333dc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Vaccination
    140 rdf:type schema:DefinedTerm
    141 N14717a2dbdec4e7f9899a45a3df385b8 schema:issueNumber 9
    142 rdf:type schema:PublicationIssue
    143 N17c01db3b1664369bb5d4b8ce0c1d326 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Sweden
    145 rdf:type schema:DefinedTerm
    146 N1b009886208f4b13828505c0ec632dcc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Prospective Studies
    148 rdf:type schema:DefinedTerm
    149 N1c699812ed054f6f8dce8cbf464beda9 rdf:first sg:person.0717435623.02
    150 rdf:rest N46d464c7f5c247f9af607a79f68a21f9
    151 N23a7f9daaaf6484f80dc816eacb1e532 schema:volumeNumber 165
    152 rdf:type schema:PublicationVolume
    153 N34e40dc06f6947a595c4a0d781a9ed14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Female
    155 rdf:type schema:DefinedTerm
    156 N3554944d37ae4ba18a5c3311f83a5ba3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Serologic Tests
    158 rdf:type schema:DefinedTerm
    159 N3f923e40e73e46089d0498bfe489bd3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Bacterial Vaccines
    161 rdf:type schema:DefinedTerm
    162 N40b42c373f5c413bbbf117dfad861ef6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Immunoglobulin A
    164 rdf:type schema:DefinedTerm
    165 N4520acea0e564b0fac12363d516b4103 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name RNA Virus Infections
    167 rdf:type schema:DefinedTerm
    168 N46d464c7f5c247f9af607a79f68a21f9 rdf:first sg:person.0646625744.89
    169 rdf:rest N681424749f28450484abfd2ddb2489e6
    170 N48c6f598d30147819ef4767133742ad2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Fluorescent Antibody Technique
    172 rdf:type schema:DefinedTerm
    173 N56f97bd5e0e14638a50c3ef44297eab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Immunoglobulin G
    175 rdf:type schema:DefinedTerm
    176 N6540303ae38c491997e97572f6c85c6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Child, Preschool
    178 rdf:type schema:DefinedTerm
    179 N681424749f28450484abfd2ddb2489e6 rdf:first sg:person.0704771463.02
    180 rdf:rest rdf:nil
    181 N6c56fb43f1154a6492d868149f783ec2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Viral Vaccines
    183 rdf:type schema:DefinedTerm
    184 N7ffb69a5df38413b97c9a1273dfd626a schema:name Springer Nature - SN SciGraph project
    185 rdf:type schema:Organization
    186 N816702b4c27c472cb62c9e6ec64f9b6c rdf:first sg:person.01044643445.69
    187 rdf:rest N0ab1304648804cf7bf6aeafcb04d4b84
    188 N9080fbf7fca24ece9e1e2bc81b0639cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Guillain-Barre Syndrome
    190 rdf:type schema:DefinedTerm
    191 N917c878e73134dfcabef5d0088168cb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Immunoglobulin M
    193 rdf:type schema:DefinedTerm
    194 N91bddd1b5e374850bef2bdd8a43dd24a schema:name dimensions_id
    195 schema:value pub.1017397789
    196 rdf:type schema:PropertyValue
    197 N9314dc5bc2614f5aa44097a404fcd7de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Child
    199 rdf:type schema:DefinedTerm
    200 N9a1caa90fc984db28dce68687c9ba18b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Gram-Negative Bacterial Infections
    202 rdf:type schema:DefinedTerm
    203 N9c746249d3a74a57a3924d0f8c20abef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Antibodies, Bacterial
    205 rdf:type schema:DefinedTerm
    206 N9cd47f74b7044f83a8453a247fe91300 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Germany
    208 rdf:type schema:DefinedTerm
    209 Nb503077d02e744b4bfece40c10bf22f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name DNA Virus Infections
    211 rdf:type schema:DefinedTerm
    212 Nb5c45a001f004bfaa75377a61be568e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Male
    214 rdf:type schema:DefinedTerm
    215 Nbe9422873c3445d09008ea2597db303c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Austria
    217 rdf:type schema:DefinedTerm
    218 Nc6037757ade74ceb903bb4e0417e741e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Gram-Negative Bacteria
    220 rdf:type schema:DefinedTerm
    221 Nc6add0aecfff48fc8ecb9aa578c6a670 schema:name pubmed_id
    222 schema:value 16691408
    223 rdf:type schema:PropertyValue
    224 Nc7fa35b995594ba8957a851e8f8f260a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name DNA Viruses
    226 rdf:type schema:DefinedTerm
    227 Ncee9c762fc9349ddb76bdfdfa7c1c34d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Adolescent
    229 rdf:type schema:DefinedTerm
    230 Nd57ec34405c34dc6ab5c1b671203b906 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    231 schema:name Immunoenzyme Techniques
    232 rdf:type schema:DefinedTerm
    233 Nd981269156154b7ba1b612e53c783cc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Antibodies, Viral
    235 rdf:type schema:DefinedTerm
    236 Nda2dbe47d3374125afc7fcb09a9eb0da schema:name doi
    237 schema:value 10.1007/s00431-006-0140-1
    238 rdf:type schema:PropertyValue
    239 Necd7667c0c9647e58ba9c3c6e45b3367 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    240 schema:name Humans
    241 rdf:type schema:DefinedTerm
    242 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    243 schema:name Medical and Health Sciences
    244 rdf:type schema:DefinedTerm
    245 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    246 schema:name Clinical Sciences
    247 rdf:type schema:DefinedTerm
    248 sg:journal.1017354 schema:issn 0340-6199
    249 1432-1076
    250 schema:name European Journal of Pediatrics
    251 schema:publisher Springer Nature
    252 rdf:type schema:Periodical
    253 sg:person.01044643445.69 schema:affiliation grid-institutes:grid.7708.8
    254 schema:familyName Schessl
    255 schema:givenName Joachim
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044643445.69
    257 rdf:type schema:Person
    258 sg:person.01126132362.31 schema:affiliation grid-institutes:None
    259 schema:familyName Luther
    260 schema:givenName Birgit
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126132362.31
    262 rdf:type schema:Person
    263 sg:person.0646625744.89 schema:affiliation grid-institutes:None
    264 schema:familyName Mauff
    265 schema:givenName Gottfried
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646625744.89
    267 rdf:type schema:Person
    268 sg:person.0704771463.02 schema:affiliation grid-institutes:grid.7708.8
    269 schema:familyName Korinthenberg
    270 schema:givenName Rudolf
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704771463.02
    272 rdf:type schema:Person
    273 sg:person.0717435623.02 schema:affiliation grid-institutes:grid.7708.8
    274 schema:familyName Kirschner
    275 schema:givenName Janbernd
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717435623.02
    277 rdf:type schema:Person
    278 sg:pub.10.1007/978-1-4471-3175-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033981631
    279 https://doi.org/10.1007/978-1-4471-3175-5
    280 rdf:type schema:CreativeWork
    281 grid-institutes:None schema:alternateName Department of Clinical Microbiology and Hygiene, Institute of Hygiene and Environment, Hamburg, Germany
    282 Laboratory Dr. Kramer and Colleagues, Geesthacht, Germany
    283 schema:name Department of Clinical Microbiology and Hygiene, Institute of Hygiene and Environment, Hamburg, Germany
    284 Laboratory Dr. Kramer and Colleagues, Geesthacht, Germany
    285 rdf:type schema:Organization
    286 grid-institutes:grid.7708.8 schema:alternateName Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany
    287 schema:name Division of Neuropaediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstr. 1, 79106, Freiburg, Germany
    288 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...